Titre : Calicules gustatifs

Calicules gustatifs : Questions médicales fréquentes

Termes MeSH sélectionnés :

Receptor Activity-Modifying Protein 2
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Calicules gustatifs : Questions médicales les plus fréquentes", "headline": "Calicules gustatifs : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Calicules gustatifs : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-02", "dateModified": "2025-04-27", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Calicules gustatifs" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Langue", "url": "https://questionsmedicales.fr/mesh/D014059", "about": { "@type": "MedicalCondition", "name": "Langue", "code": { "@type": "MedicalCode", "code": "D014059", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A14.549.885" } } }, "about": { "@type": "MedicalCondition", "name": "Calicules gustatifs", "alternateName": "Taste Buds", "code": { "@type": "MedicalCode", "code": "D013650", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Thomas E Finger", "url": "https://questionsmedicales.fr/author/Thomas%20E%20Finger", "affiliation": { "@type": "Organization", "name": "Rocky Mountain Taste and Smell Center, University of Colorado School of Medicine, CU Anschutz Medical Campus, Aurora, Colorado 80045 tom.finger@cuanschutz.edu." } }, { "@type": "Person", "name": "Hong-Xiang Liu", "url": "https://questionsmedicales.fr/author/Hong-Xiang%20Liu", "affiliation": { "@type": "Organization", "name": "Regenerative Bioscience Center, Department of Animal and Dairy Science, College of Agricultural and Environmental Sciences, University of Georgia, Athens, GA, USA. Electronic address: lhx@uga.edu." } }, { "@type": "Person", "name": "Yuta Yoshida", "url": "https://questionsmedicales.fr/author/Yuta%20Yoshida", "affiliation": { "@type": "Organization", "name": "Regenerative Bioscience Center, University of Georgia, Athens, GA, USA; Department of Animal and Dairy Science, College of Agricultural and Environmental Sciences, University of Georgia, Athens, GA, USA; Laboratory of Functional Anatomy, Faculty of Agriculture, Kyushu University, Fukuoka, Japan." } }, { "@type": "Person", "name": "Fuminori Kawabata", "url": "https://questionsmedicales.fr/author/Fuminori%20Kawabata", "affiliation": { "@type": "Organization", "name": "Faculty of Agriculture and Life Science, Hirosaki University, Hirosaki, Japan." } }, { "@type": "Person", "name": "Shoji Tabata", "url": "https://questionsmedicales.fr/author/Shoji%20Tabata", "affiliation": { "@type": "Organization", "name": "Laboratory of Functional Anatomy, Faculty of Agriculture, Kyushu University, Fukuoka, Japan." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Recurrent Abortion and the Involvement of Killer-Cell Immunoglobulin-like Receptor (KIR) Genes, Activated T Cells, NK Abnormalities, and Cytokine Profiles.", "datePublished": "2023-02-08", "url": "https://questionsmedicales.fr/article/36835892", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/jcm12041355" } }, { "@type": "ScholarlyArticle", "name": "Effector-dependent activation and oligomerization of plant NRC class helper NLRs by sensor NLR immune receptors Rpi-amr3 and Rpi-amr1.", "datePublished": "2023-01-02", "url": "https://questionsmedicales.fr/article/36592032", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.15252/embj.2022111484" } }, { "@type": "ScholarlyArticle", "name": "Clinical characteristics and efficacy of pioglitazone in a Japanese patient with familial partial lipodystrophy due to peroxisome proliferator-activated receptor γ gene mutation.", "datePublished": "2022-09-29", "url": "https://questionsmedicales.fr/article/36171144", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1507/endocrj.EJ22-0140" } }, { "@type": "ScholarlyArticle", "name": "Farnesoid X Receptor Overexpression Decreases the Migration, Invasion and Angiogenesis of Human Bladder Cancers via AMPK Activation and Cholesterol Biosynthesis Inhibition.", "datePublished": "2022-09-09", "url": "https://questionsmedicales.fr/article/36139556", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/cancers14184398" } }, { "@type": "ScholarlyArticle", "name": "DNA methylation-induced ablation of miR-133a accelerates cancer aggressiveness in glioma through upregulating peroxisome proliferator-activated receptor γ.", "datePublished": "2022-09-05", "url": "https://questionsmedicales.fr/article/36067936", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.slasd.2022.08.004" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Système stomatognathique", "item": "https://questionsmedicales.fr/mesh/D013284" }, { "@type": "ListItem", "position": 3, "name": "Bouche", "item": "https://questionsmedicales.fr/mesh/D009055" }, { "@type": "ListItem", "position": 4, "name": "Langue", "item": "https://questionsmedicales.fr/mesh/D014059" }, { "@type": "ListItem", "position": 5, "name": "Calicules gustatifs", "item": "https://questionsmedicales.fr/mesh/D013650" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Calicules gustatifs - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Calicules gustatifs", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-19", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Général", "headline": "Général sur Calicules gustatifs", "description": "Erreur lors de la génération.", "url": "https://questionsmedicales.fr/mesh/D013650?mesh_terms=Receptor+Activity-Modifying+Protein+2&page=1000#section-général" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Erreur lors de la génération.", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Veuillez réessayer ultérieurement." } } ] } ] }

Sources (10000 au total)

Clinical characteristics and efficacy of pioglitazone in a Japanese patient with familial partial lipodystrophy due to peroxisome proliferator-activated receptor γ gene mutation.

Familial partial lipodystrophy (FPLD) 3 is a rare genetic disorder caused by peroxisome proliferator-activated receptor γ gene (PPARG) mutations. Most cases have been reported in Western patients. Her...

Lifestyle modifies the associations of early-life smoking behaviors and genetic susceptibility with type 2 diabetes: A prospective cohort study involving 433,872 individuals from UK Biobank.

To investigate whether and what lifestyle factors in later life modify the associations of early-life smoking behaviors and genetic susceptibility with type 2 diabetes (T2D).... In the UK Biobank, in utero tobacco exposure (n = 354,493) and age of smoking initiation (n = 353,557) were self-reported. A composite lifestyle score was calculated based on diet, physical activity, ... During a median follow-up of 14.6 years, the HRs (95 % CIs) of T2D for in utero tobacco exposure, and smoking initiation in adulthood, adolescence, and childhood, compared with no smoking behavior, we... The T2D risk associated with early-life smoking behaviors and genetic risk was modified by a favorable lifestyle....

Implementing a contextually appropriate foot-ankle exercise programme in primary care for the prevention of modifiable risk factors for ulcers in people with diabetes: protocol for a hybrid type 2 study.

Diabetes is a highly prevalent disease that negatively impacts people's health and quality of life. It can result in diabetic peripheral neuropathy (DPN) and foot complications, which in turn lead to ... This is a hybrid type 2 implementation-effectiveness study organised in four phases, being undertaken in Limeira, São Paulo. Phase 1, preimplementation, aims to gather information about the contextual... This protocol and the informed consent to be signed by the participants were approved by the Ethics Committee of the School of Medicine of the University of São Paulo (CAAE:63457822.0.0000.0068, 29 No... NCT05639478....